Published in PLoS One on June 13, 2014
Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1. PLoS One (2015) 0.82
Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals. World J Stem Cells (2015) 0.80
Clinical implications of basic science discoveries: induced pluripotent stem cell therapy in transplantation--a potential role for immunologic tolerance. Am J Transplant (2015) 0.77
Production of a Locus- and Allele-Specific Monoclonal Antibody for the Characterization of SLA-1*0401 mRNA and Protein Expression Levels in MHC-Defined Microminipigs. PLoS One (2016) 0.75
Histopathological background data of the systemic organs of CLAWN miniature swine with coronary artery stent implantation. J Toxicol Pathol (2016) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41
A more efficient method to generate integration-free human iPS cells. Nat Methods (2011) 7.39
Role of CD47 as a marker of self on red blood cells. Science (2000) 7.00
CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell (2009) 5.22
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature (2013) 4.19
Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b. J Immunol (1979) 3.50
Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation (1976) 3.41
Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science (2012) 3.03
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell (2013) 2.45
Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol (2006) 1.80
Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A (2007) 1.80
Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell (2012) 1.75
Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A (2010) 1.67
HLA-haplotype banking and iPS cells. Nat Biotechnol (2008) 1.61
Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate. Stem Cell Reports (2013) 1.48
Histocompatible miniature swine: an inbred large-animal model. Transplantation (2003) 1.33
The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PLoS One (2008) 1.29
Generation of naive-like porcine-induced pluripotent stem cells capable of contributing to embryonic and fetal development. Stem Cells Dev (2012) 1.27
Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep (2013) 1.26
Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia (2012) 1.25
The pig as a xenograft donor. Pathol Biol (Paris) (1994) 1.14
Mesenchymal stem cells are injured by complement after their contact with serum. Blood (2012) 1.09
Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells. FASEB J (2010) 1.08
Natural immunity to pluripotency antigen OCT4 in humans. Proc Natl Acad Sci U S A (2010) 1.06
Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Stem Cells Dev (2012) 1.02
To be immunogenic, or not to be: that's the iPSC question. Cell Stem Cell (2013) 0.98
The Göttingen minipig in pharmacology and toxicology. Pharmacol Toxicol (1997) 0.95
Complement-dependent control of teratoma formation by embryonic stem cells. J Immunol (2006) 0.91
Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions. PLoS One (2013) 0.91
Rapid assignment of the swine major histocompatibility complex (SLA) class I and II genotypes in Clawn miniature swine using PCR-SSP and PCR-RFLP methods. Xenotransplantation (2005) 0.89
Genetic polymorphism of the swine major histocompatibility complex ( SLA) class I genes, SLA-1, -2 and -3. Immunogenetics (2003) 0.83
Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice. Cell Transplant (2008) 0.81
Cytoplasmic inheritance of transplantation antigens in animals produced by nuclear transfer. Transplantation (2009) 0.81
Two-step differentiation of mast cells from induced pluripotent stem cells. Stem Cells Dev (2012) 0.80
Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donor. J Pediatr Hematol Oncol (2003) 0.80
Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors. Biol Blood Marrow Transplant (2012) 0.79